SEC Comment Letter 0000000000-23-011638 to BioCardia, Inc. (BCDA)
BioCardia, Inc.
Date: Oct. 24, 2023 · CIK: 0000925741 · Accession: 0000000000-23-011638
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-275099
Letter
United States securities and exchange commission logo October 24, 2023 Dr. Peter Altman President and Chief Executive Officer BioCardia, Inc. 320 Soquel Way Sunnyvale, California 94085 Re:BioCardia, Inc. Registration Statement on Form S-3 Filed October 19, 2023 File No. 333-275099 Dear Dr. Peter Altman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Cindy Polynice at 202-551-8707 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Michael Danaher
Show Raw Text
United States securities and exchange commission logo
October 24, 2023
Dr. Peter Altman
President and Chief Executive Officer
BioCardia, Inc.
320 Soquel Way
Sunnyvale, California 94085
Re:BioCardia, Inc.
Registration Statement on Form S-3
Filed October 19, 2023
File No. 333-275099
Dear Dr. Peter Altman:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Cindy Polynice at 202-551-8707 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Michael Danaher